发明名称 Quinoline derivatives
摘要 The invention is related to compounds of general formula (I), wherein R is methyl, ethyl, n-propyl, iso-propyl, n-butyl or allyl; R' is methyl, methoxy, fluoro, chloro, bromo, trifluoromethyl, or OCHxFy, wherein x = O - 2, y = 1 - 3 with the proviso that x + y = 3; R'' is hydrogen, fluoro or chloro; with the proviso that R'' is fluoro or chloro only when R' is fluoro; R4 is hydrogen or pharmaceutically acceptable inorganic or organic cations; R5 is ethyl, n-propyl, iso-propyl, methoxy, ethoxy, chloro, bromo, trifluoromethyl, OCHxFy, or OCH2CHxFy wherein x = 0 - 2, y = 1 - 3 with the proviso that x + y = 3; R6 is hydrogen; or R5, and R6 taken together are methylenedioxy; and any tautomer thereof. The invention also relates to pharmaceutical compositions containing a compound of general formula (I) together with a pharmaceutically acceptable carrier. Included are also processes for the preparation of the compounds of formula (I), as well as methods for the treatment of mammals suffering from diseases resulting from autoimmunity and pathological inflammation by administering of a compound having formula (I) to said mammal.
申请公布号 AU4950499(A) 申请公布日期 2000.02.07
申请号 AU19990049504 申请日期 1999.07.14
申请人 ACTIVE BIOTECH AB 发明人 ANDERS BJORK;STIG JONSSON;TOMAS FEX;GUNNAR HEDLUND
分类号 C07D215/56;A61K31/47;A61K31/4741;A61P1/04;A61P3/10;A61P9/10;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P25/00;A61P25/28;A61P29/00;C07D215/18;C07D215/22;C07D491/04;C07D491/056 主分类号 C07D215/56
代理机构 代理人
主权项
地址